Becton Dickinson and Company (BDX)vsHologic Inc (HOLX)
BDX
Becton Dickinson and Company
$154.13
-1.53%
HEALTHCARE · Cap: $55.84B
HOLX
Hologic Inc
$75.41
+0.11%
HEALTHCARE · Cap: $16.83B
Smart Verdict
WallStSmart Research — data-driven comparison
Becton Dickinson and Company generates 431% more annual revenue ($21.92B vs $4.13B). HOLX leads profitability with a 13.2% profit margin vs 8.0%. BDX appears more attractively valued with a PEG of 1.18. BDX earns a higher WallStSmart Score of 61/100 (C+).
BDX
Buy61
out of 100
Grade: C+
HOLX
Buy51
out of 100
Grade: C-
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
+36.0%
Fair Value
$282.20
Current Price
$154.13
$128.07 discount
Margin of Safety
-358.1%
Fair Value
$16.39
Current Price
$75.41
$59.02 premium
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Large-cap with strong market position
Reasonable price relative to book value
Earnings expanding 28.6% YoY
Strong operational efficiency at 23.0%
Areas to Watch
Moderate valuation
1.6% revenue growth
ROE of 7.0% — below average capital efficiency
Distress zone — elevated risk
Expensive relative to growth rate
Premium valuation, high expectations priced in
2.5% revenue growth
Earnings declined 9.2%
Comparative Analysis Report
WallStSmart ResearchBull Case : BDX
The strongest argument for BDX centers on Market Cap, Price/Book, EPS Growth. PEG of 1.18 suggests the stock is reasonably priced for its growth.
Bull Case : HOLX
The strongest argument for HOLX centers on Operating Margin.
Bear Case : BDX
The primary concerns for BDX are P/E Ratio, Revenue Growth, Return on Equity.
Bear Case : HOLX
The primary concerns for HOLX are PEG Ratio, P/E Ratio, Revenue Growth.
Key Dynamics to Monitor
HOLX carries more volatility with a beta of 0.73 — expect wider price swings.
HOLX is growing revenue faster at 2.5% — sustainability is the question.
BDX generates stronger free cash flow (549M), providing more financial flexibility.
Monitor MEDICAL INSTRUMENTS & SUPPLIES industry trends, competitive dynamics, and regulatory changes.
Bottom Line
BDX scores higher overall (61/100 vs 51/100). Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Becton Dickinson and Company
HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES · USA
Becton, Dickinson and Company, also known as BD, is an American multinational medical technology company that manufactures and sells medical devices, instrument systems, and reagents. BD also provides consulting and analytics services in certain geographies.
Visit Website →Hologic Inc
HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES · USA
Hologic, Inc. is a medical technology company primarily focused on women's health; it sells medical devices for diagnostics, surgery, and medical imaging.
Visit Website →Compare with Other MEDICAL INSTRUMENTS & SUPPLIES Stocks
Want to dig deeper into these stocks?